|
PARATHYROID
Primary Paraganglioma of the Parathyroid:
A Case Report and Clinicopathologic Review.
Levy MT, Braun JT, Pennant M, Thompson LDR.
Head and Neck Pathol J. 2009-12-24.
Paragangliomas are relatively uncommon neoplasms that arise in
adrenal and extra-adrenal paraganglia of the autonomic nervous
system. Parasympathetic paraganglioma develop predominantly in the
head and neck. It is exceedingly uncommon to develop a primary
intraparathyroid paraganglioma. There is only a single case report
in the English literature. The information from the single previous
case report (Medline 1960–2009) was combined with this case report.
Our patient was a 69 year old woman who presented with a thyroid
gland mass, with extension into the substernal space. The patient
had a history of renal cell carcinoma removed 18 months before. At
surgery, a thyroid lobectomy and a parathyroidectomy were performed.
The parathyroid tissue showed a very well defined zellballen
arrangement of paraganglion cells within the parenchyma of the
parathyroid gland. The cells had ample basophilic, granular
cytoplasm. The nuclei were generally round to oval with
‘salt-and-pepper’ nuclear chromatin distribution. There was a richly
vascularized stroma. Mitotic figures, necrosis, invasive growth, and
profound nuclear pleomorphism were absent. The neoplastic cells were
strongly and diffusely immunoreactive with chromogranin,
synaptophysin, CD56, and focally with cyclin-D1. The paraganglioma
showed a delicate S-100 protein positive supporting sustentacular
framework. Keratin, CD10, PTH, calcitonin and RCC markers were
negative. The patient showed no stigmata of Multiple Endocrine
Neoplasia (MEN) and has no paraganglioma in any other anatomic site.
She is alive without any additional findings 12 months after
surgery. Isolated paraganglioma within the parathyroid is rare, and
should be separated from parathyroid adenoma, hyperplasia or
metastatic disease to assure appropriate management.
PMID: to be determined
See full article (<1 MB .pdf)
Parathyroid carcinoma.
Thompson LDR.
Ear Nose Throat J. 2008 Sep; 87(9):502-504.
FIRST PARAGRAPH:
Parathyroid carcinoma is rare, comprising less than 1% of all cases
of primary hyperparathyroidism. Parathyroid carcinoma occurs in
patients of all ages, and there is no predilection for either sex.
Its clinical features are primarily attributable to the effects of
hypercalcemia and excessive secretion of parathyroid hormone (PTH).
Most of its symptoms--weakness, fatigue, anorexia, weight loss, and
nausea--are nonspecific, but an excessively high serum calcium level
(>16 mg/dl) can be associated with nephrolithiasis, renal
insufficiency, and bone "brown tumors." A palpable neck mass
suggests a parathyroid carcinoma. Parathyroid carcinoma is a
suggested component of hyperparathyroidism-jaw tumor syndrome.
PMID: 18800320
See full article (<1 MB .pdf)
Primary parathyroid hyperplasia.
Penner CR, Thompson LD.
Ear Nose Throat J. 2003 May;82(5):363.
FIRST PARAGRAPH: Parathyroid hyperplasia is classified as either
primary, secondary, or tertiary. Primary parathyroid hyperplasia
occurs in approximately 15% of patients with hyperparathyroidism.
Most cases are sporadic, and they usually occur in patients who are
middle-aged and older. Approximately 20% of all cases of primary
chief-cell hyperplasia are associated with one of the multiple
endocrine neoplasia syndromes. Symptoms are referable to the level
and duration of serum calcium elevation, although routine
biochemical testing has led to an increase in the identification of
asymptomatic patients. Biochemically, ionized serum calcium levels
are elevated, and serum phosphorus concentrations are lowered.
Technetium-99m sestamibi imaging successfully localizes as many as
60% of hyperplastic glands, although this technique is significantly
more effective in localizing adenomas and carcinomas. Therefore, at
least two glands should be examined histologically to confirm the
diagnosis.
PMID: 12789760
See full article (<1 MB .pdf)
Parathyroiditis.
Thompson LD.
Ear Nose Throat J. 2005 Oct;84(10):636.
FIRST PARAGRAPH: Parathyroiditis is a rare and poorly understood
condition. Chronic parathyroiditis may occur in patients with
hypoparathyroidism, as well as in those with primary chief-cell
hyperplasia. Most patients are asymptomatic. Antibodies to
parathyroid tissue are seen in only a few cases of parathyroiditis.
It is thought that parathyroiditis represents an autoimmune process
similar to thyroid gland Hashimoto’s disease. The presence of
seronegative cases of parathyroiditis does not rule against an
autoimmune etiology, because a similar phenomenon is observed in
Hashimoto’s thyroiditis. Based on this assumption, it is believed
that the lymphocytic infiltration is an ongoing destructive process.
PMID: 16382744
See full article (<1 MB .pdf)
Parathyroid carcinoma occurring in
multiple endocrine neoplasia type 1.
Kodroff KS, Lieber C, Thompson LDR
Endocr Pract 1999;5:347-349
Objective: To describe a patient with multiple endocrine neoplasia
type I (MEN-I) in whom parathyroid carcinoma developed.
Methods: A case report is presented, including detailed history,
laboratory findings, and pathologic features.
Results: A 49-year-old man with a known history of MEN-I syndrome
had hypercalcemia and profoundly increased parathyroid hormone
levels. Seven years earlier, he had been diagnosed with a
gastrinoma, prolactinoma, and primary hyperparathyroidism. A neck
exploration at that time consisted of resection of a right inferior
parathyroid gland and parathyroid tissue in the thyroid gland as
well as biopsies of two left-sided glands, after which microscopic
examination revealed parathyroid hyperplasia and his serum calcium
levels normalized. On reexploration of the neck, resection revealed
pathologic f~ndings consistent with parathyroid carcinoma.
Conclusion: Parathyroid carcinoma has rarely been reported in the
setting of MEN-I. This case illustrates the need for near-complete
resection of parathyroid tissue in the patient with MEN-I. Subtotal
or total parathyroidectomy in conjunction with forearm
autotransplantation should be performed, not simply to prevent
recurrence of benign disease but also to prevent the potential
development of carcinoma over time.
PMID: 0
See full article (<1 MB .pdf)
|